Preparation of bulk sampling trial mining area, Steelpoortdrift project, South Africa. Source: Vanadium Resources
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Vanadium Resources (ASX:VR8) winds up the December quarter with a net present value of more than US$1 billion
  • This was achieved by increasing a stake in a subsidiary to 86.49 per cent after a transaction with third-party entities Obeec and Math-Pin
  • Preliminary work for the company’s Steelpoortdrift vanadium project continues to roll along with FEED works coming together on schedule
  • Shares last traded at 3.8 cents

Vanadium Resources (ASX:VR8) wound up the December quarter with a net present value of more than US$1 billion.

This was achieved by increasing a stake in a subsidiary to 86.49 per cent after a transaction with third-party entities Obeec and Math-Pin.

Preliminary work for the company’s Steelpoortdrift vanadium project continues to roll along with front-end engineering design (FEED) works coming together on schedule.

That project, once live, will be based in South Africa.

Contracts for works

The company expects to start firing off other contracts later this year with a view towards engineering, procurement and construction.

The company also received public comment through the environmental approvals process during Q2 FY24.

Other social licence activities were undertaken as well as an assessment of solar power and rope conveyors to be in use on-site at the future fully-developed project.

Offtake and financing

Offtake negotiations, as well as those for investment into the project, are taking place with International entities, the company reported in its quarterly today.

In October the company reported heading towards FID.

Shares last traded at 3.8 cents.

VR8 by the numbers
More From The Market Online
The Market Online Video

Daily ASX Market Close: Late run sees market lift 1%, May 31, 2024

The ASX200 took a late uptick to be add almost a per cent at close this…

Little Green Pharma’s cannabis sales leap 30%

Little Green Pharma saw sales leap 30% to $25.6 million in the financial year to March…

Week 22 Wrap: ASX200 anxious; Macquarie see June correction in US markets

The Australian Bureau of Statistics (ABS) has released Australia's latest retail data, showing growth is up…